The Legal Dispute
Apple’s injunction request follows an earlier lawsuit alleging trade-secret theft:
- Initial allegations: Former employees took confidential AI research to OpenAI
- Expanded scope: 11 additional ex-employees may have taken confidential data
- Injunction sought: Court order restricting OpenAI’s use of the disputed technology
- Timing: Filed as OpenAI prepares for its public IPO filing
The case adds to OpenAI’s legal challenges, which include the US Treasury’s systemic risk analysis and ongoing scrutiny of its safety practices.
The Revamped Siri
The same week, Apple’s redesigned Siri arrived in the iOS 27 beta:
- Natural conversation: Back-and-forth dialogue without wake-word repetition
- Personal-context understanding: Draws on messages, calendar, photos, and email
- Gemini-powered: Built on Apple’s Google Gemini partnership
- On-device privacy: Apple continues its on-device processing approach
The timing is notable: Apple is shipping the Siri overhaul it has promised for years, just as it battles OpenAI in court over the employees who may have helped build the technology.
The Tension
Apple’s position is delicate:
- Legal conflict: Suing OpenAI for using Apple research
- Technical dependence: Siri itself relies on Google Gemini — an OpenAI competitor
- Strategy: Apple has avoided building its own frontier models, partnering instead
The trade-secrets case highlights the fierce competition for AI talent. Apple has lost AI researchers to OpenAI, Anthropic, and Meta in recent years — and is now trying to claw back the value of what they took.
Industry Implications
- Talent wars: AI talent movement is increasingly litigious
- IP enforcement: Companies are asserting trade-secret protection aggressively
- IPO risk: The case could complicate OpenAI’s upcoming public filing
- Siri’s comeback: The revamped Siri is Apple’s most significant AI consumer product in years
For the AI industry, the Apple-OpenAI dispute shows that as AI capability becomes the most valuable corporate asset, the battle over who owns it will intensify — in courts as well as in the lab.